एंज़लुटामाइड एंज़ाना कैप्सूल

उत्पाद वर्णन

Enzalutamide, sold under the brand name "Enzana" in capsule form, typically comes in a strength of 40 mg. Enzalutamide is a medication used in the treatment of prostate cancer. Here's an overview of its use:

1. Metastatic Prostate Cancer Enzalutamide is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This is a type of prostate cancer that has spread beyond the prostate gland and is no longer responsive to hormone therapy (androgen deprivation therapy or ADT).

Enzalutamide is an androgen receptor inhibitor. It works by blocking the activity of androgen receptors on prostate cancer cells, thereby inhibiting the growth and spread of the cancer. It also decreases the production of prostate-specific antigen (PSA), a protein that is often elevated in prostate cancer.

Enzalutamide capsules are typically taken orally once daily, with or without food. The dosage and treatment duration may vary depending on factors such as the stage of prostate cancer, overall health, and individual response to treatment.

Common side effects of enzalutamide may include fatigue, hot flashes, hypertension (high blood pressure), diarrhea, nausea, and musculoskeletal pain. It's important for patients to be monitored closely by their healthcare provider while taking enzalutamide to manage any side effects and ensure the treatment remains effective.

As with any cancer treatment, it's crucial to discuss the potential benefits and risks with a healthcare professional to make informed decisions about treatment options.